Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.

Sekiguchi F, Fujita T, Deguchi T, Yamaoka S, Tomochika K, Tsubota M, Ono S, Horaguchi Y, Ichii M, Ichikawa M, Ueno Y, Koike N, Tanino T, Nguyen HD, Okada T, Nishikawa H, Yoshida S, Ohkubo T, Toyooka N, Murata K, Matsuda H, Kawabata A.

Neuropharmacology. 2018 Aug;138:232-244. doi: 10.1016/j.neuropharm.2018.06.020. Epub 2018 Jun 18.

PMID:
29913186
2.

Effects of peanut-skin procyanidin A1 on degranulation of RBL-2H3 cells.

Tomochika K, Shimizu-Ibuka A, Tamura T, Mura K, Abe N, Onose J, Arai S.

Biosci Biotechnol Biochem. 2011;75(9):1644-8. Epub 2011 Sep 7.

3.

Detection and isolation of nanobacteria-like particles from urinary stones: long-withheld data.

Kumon H, Matsumoto A, Uehara S, Abarzua F, Araki M, Tsutsui K, Tomochika K.

Int J Urol. 2011 Jun;18(6):458-65. doi: 10.1111/j.1442-2042.2011.02763.x. Epub 2011 Apr 13.

4.

Clinical characteristics of respiratory syncytial virus infection-associated acute otitis media.

Tomochika K, Ichiyama T, Shimogori H, Sugahara K, Yamashita H, Furukawa S.

Pediatr Int. 2009 Aug;51(4):484-7. doi: 10.1111/j.1442-200X.2008.02768.x.

PMID:
19674360
5.

Dexamethasone decreases cerebrospinal fluid soluble tumor necrosis factor receptor 1 levels in bacterial meningitis.

Ichiyama T, Matsushige T, Kajimoto M, Tomochika K, Matsubara T, Furukawa S.

Brain Dev. 2008 Feb;30(2):95-9. Epub 2007 Jul 30.

PMID:
17664049
6.
7.

Distribution of virulence-associated genes in Vibrio mimicus isolates from clinical and environmental origins.

Shinoda S, Nakagawa T, Shi L, Bi K, Kanoh Y, Tomochika K, Miyoshi S, Shimada T.

Microbiol Immunol. 2004;48(7):547-51.

8.

High growing ability of Vibrio vulnificus biotype 1 is essential for production of a toxic metalloprotease causing systemic diseases in humans.

Watanabe H, Miyoshi S, Kawase T, Tomochika K, Shinoda S.

Microb Pathog. 2004 Mar;36(3):117-23.

PMID:
14726228
9.

Histamine-releasing reaction induced by the N-terminal domain of Vibrio vulnificus metalloprotease.

Miyoshi S, Kawata K, Hosokawa M, Tomochika K, Shinoda S.

Life Sci. 2003 Apr 4;72(20):2235-42.

PMID:
12628443
10.

An exocellular thermolysin-like metalloprotease produced by Vibrio fluvialis: purification, characterization, and gene cloning.

Miyoshi S, Sonoda Y, Wakiyama H, Rahman MM, Tomochika K, Shinoda S, Yamamoto S, Tobe K.

Microb Pathog. 2002 Sep;33(3):127-34.

PMID:
12220989
11.

Purification of a serine protease of Vibrio parahaemolyticus and its characterization.

Ishihara M, Kawanishi A, Watanabe H, Tomochika K, Miyoshi S, Shinoda S.

Microbiol Immunol. 2002;46(4):298-303.

12.

Environmental investigation of potentially pathogenic Vibrio parahaemolyticus in the Seto-Inland Sea, Japan.

Alam MJ, Tomochika KI, Miyoshi SI, Shinoda S.

FEMS Microbiol Lett. 2002 Feb 19;208(1):83-7.

13.

Specificity of a heme-assimilating system of Vibrio vulnificus to synthetic heme compounds.

Miyoshi S, Kamei T, Ota Y, Masunaga C, Izuhara Y, Tomochika K, Shinoda S, Yamamoto S.

FEMS Microbiol Lett. 2002 Feb 19;208(1):77-81.

14.

The C-terminal domain promotes the hemorrhagic damage caused by Vibrio vulnificus metalloprotease.

Miyoshi S, Kawata K, Tomochika K, Shinoda S, Yamamoto S.

Toxicon. 2001 Dec;39(12):1883-6.

PMID:
11600151
15.

Detection of virulence associated genes in clinical strains of vibrio mimicus.

Bi K, Miyoshi SI, Tomochika KI, Shinoda S.

Microbiol Immunol. 2001;45(8):613-6.

16.

Analysis of seawaters for the recovery of culturable Vibrio parahaemolyticus and some other vibrios.

Alam MJ, Tomochika K, Miyoshi S, Shinoda S.

Microbiol Immunol. 2001;45(5):393-7.

17.

Purification and characterization of 2-ethoxyphenol-induced cytochrome P450 from Corynebacterium sp. strain EP1.

Kawahara N, Ikatsu H, Kawata H, Miyoshi S, Tomochika K, Sinoda S.

Can J Microbiol. 1999 Oct;45(10):833-9.

PMID:
10907420
18.

Analysis of Vibrio mimicus clinical strains by arbitrarily primed polymerase chain reaction.

Bi K, Shi L, Maehara Y, Miyoshi S, Tomochika K, Shinoda S.

Microbiol Immunol. 2000;44(2):149-53.

19.

Role of the sulphate assimilation pathway in utilization of glutathione as a sulphur source by Saccharomyces cerevisiae.

Miyake T, Sammoto H, Kanayama M, Tomochika Ki, Shinoda S, Ono Bi.

Yeast. 1999 Oct;15(14):1449-57.

20.

The hemagglutinating action of Vibrio vulnificus metalloprotease.

Miyoshi S, Kawata K, Tomochika K, Shinoda S.

Microbiol Immunol. 1999;43(1):79-82.

21.

The ability of Vibrio vulnificus to use a synthetic hydrophilic heme compound, Fe-TPPS, as a single iron source.

Miyoshi S, Kamei T, Inami Y, Ota Y, Yamamoto S, Tomochika K, Shinoda S.

FEMS Microbiol Lett. 1999 Mar 1;172(1):73-7.

23.

Glutathione transport systems of the budding yeast Saccharomyces cerevisiae.

Miyake T, Hazu T, Yoshida S, Kanayama M, Tomochika K, Shinoda S, Ono B.

Biosci Biotechnol Biochem. 1998 Oct;62(10):1858-64.

24.

Characterization of the hemorrhagic reaction caused by Vibrio vulnificus metalloprotease, a member of the thermolysin family.

Miyoshi S, Nakazawa H, Kawata K, Tomochika K, Tobe K, Shinoda S.

Infect Immun. 1998 Oct;66(10):4851-5.

25.

Preparation and characterization of everted membrane vesicles from cells of Staphylococcus aureus.

Kodama K, Hashimoto A, Morita Y, Tomochika K, Tsuchiya T.

Biol Pharm Bull. 1998 Jan;21(1):5-9.

PMID:
9477161
26.

Functional domains of a zinc metalloprotease from Vibrio vulnificus.

Miyoshi S, Wakae H, Tomochika K, Shinoda S.

J Bacteriol. 1997 Dec;179(23):7606-9.

27.

Some properties of nicked Vibrio vulnificus hemolysin.

Miyoshi S, Fujii S, Tomochika K, Shinoda S.

Microb Pathog. 1997 Oct;23(4):235-9.

PMID:
9344784
28.

Hemagglutination is a novel biological function of lipopolysaccharide (LPS), as seen with the Vibrio cholerae O139 LPS.

Alam M, Miyoshi S, Tomochika K, Shinoda S.

Clin Diagn Lab Immunol. 1997 Sep;4(5):604-6.

29.
30.

Purification and characterization of a hemolysin produced by Vibrio mimicus.

Miyoshi S, Sasahara K, Akamatsu S, Rahman MM, Katsu T, Tomochika K, Shinoda S.

Infect Immun. 1997 May;65(5):1830-5.

31.

Vacuolar-type H(+)-ATPase in mouse bladder epithelium is responsible for urinary acidification.

Tomochika K, Shinoda S, Kumon H, Mori M, Moriyama Y, Futai M.

FEBS Lett. 1997 Mar 3;404(1):61-4.

32.

Characterization of a mutant of Vibrio vulnificus for heme utilization.

Miyoshi S, Inami Y, Moriya Y, Kamei T, Rahman MM, Yamamoto S, Tomochika K, Shinoda S.

FEMS Microbiol Lett. 1997 Mar 1;148(1):101-6.

33.

Analysis of the structural gene encoding a hemolysin in Vibrio mimicus.

Rahman MM, Miyoshi S, Tomochika K, Wakae H, Shinoda S.

Microbiol Immunol. 1997;41(2):169-73.

34.

Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells.

Hikida M, Mori M, Takai T, Tomochika K, Hamatani K, Ohmori H.

Science. 1996 Dec 20;274(5295):2092-4.

PMID:
8953042
36.

Expression of virulence-related properties by, and intestinal adhesiveness of, Vibrio mimicus strains isolated from aquatic environments.

Alam M, Miyoshi S, Yamamoto S, Tomochika K, Shinoda S.

Appl Environ Microbiol. 1996 Oct;62(10):3871-4.

37.

Microvesicles isolated from bovine posterior pituitary accumulate norepinephrine.

Moriyama Y, Yamamoto A, Yamada H, Tashiro Y, Tomochika K, Takahashi M, Maeda M, Futai M.

J Biol Chem. 1995 May 12;270(19):11424-9.

38.
40.

Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization.

Fujinaga Y, Inoue K, Shimazaki S, Tomochika K, Tsuzuki K, Fujii N, Watanabe T, Ohyama T, Takeshi K, Inoue K, et al.

Biochem Biophys Res Commun. 1994 Dec 15;205(2):1291-8.

PMID:
7802661
41.

Vibrio vulnificus may produce a metalloprotease causing an edematous skin lesion in vivo.

Miyoshi S, Hirata Y, Tomochika K, Shinoda S.

FEMS Microbiol Lett. 1994 Sep 1;121(3):321-5.

PMID:
7523241
42.

A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides.

Kumon H, Tomochika K, Matunaga T, Ogawa M, Ohmori H.

Microbiol Immunol. 1994;38(8):615-9.

43.

Suppressive effect of liposomes containing DNA coding for diphtheria toxin A-chain on cells transformed with bovine leukemia virus.

Kakidani H, Watarai S, Onuma M, Tomochika K, Yasuda T.

Microbiol Immunol. 1993;37(9):713-20.

44.

Studies on osmotic stability of liposomes prepared with bacterial membrane lipids by carboxyfluorescein release.

Nagamachi E, Hirai Y, Tomochika K, Kanemasa Y.

Microbiol Immunol. 1992;36(3):231-4.

45.

Membrane lipids of Mycoplasma orale: lipid composition and synthesis of phospholipids.

Hirai Y, Kukida S, Matsushita O, Nagamachi E, Tomochika K, Kanemasa Y.

Physiol Chem Phys Med NMR. 1992;24(1):21-7.

PMID:
1594658
46.

Establishment of a mouse model of cystitis and roles of type 1 fimbriated Escherichia coli in its pathogenesis.

Liao J, Tomochika K, Watanabe S, Kanemasa Y.

Microbiol Immunol. 1992;36(3):243-56.

47.

Adaptational changes of fatty acid composition and the physical state of membrane lipids following the change of growth temperature in Yersinia enterocolitica.

Nagamachi E, Shibuya S, Hirai Y, Matsushita O, Tomochika K, Kanemasa Y.

Microbiol Immunol. 1991;35(12):1085-93.

48.

Overproduction of truncated subunit a of H+-ATPase causes growth inhibition of Escherichia coli.

Eya S, Maeda M, Tomochika K, Kanemasa Y, Futai M.

J Bacteriol. 1989 Dec;171(12):6853-8.

49.

Efficient encapsulation of water-soluble materials into small-sized liposomes.

Tomita T, Tadakuma T, Tomochika K, Yasuda T.

Jpn J Exp Med. 1987 Apr;57(2):137-40.

PMID:
3669401
50.

Crystalline inclusion of Lactobacillus plantarum protoplast.

Tomochika K, Hirai Y, Kanemasa Y.

Microbiol Immunol. 1986;30(9):909-13. No abstract available.

Supplemental Content

Loading ...
Support Center